A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer.
about
Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the LiteratureSimultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy.Role of everolimus in the treatment of metastatic HER2-negative/HR-positive breast cancer.Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2- Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy.Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancerEfficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials.Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway.
P2860
Q26766244-0769E648-4BD6-4FCE-83AA-40BAB6CB80F0Q37628979-D18498EF-52D6-47CA-93EB-31A61E6FF5EAQ38690803-8DEC0DE5-E344-4208-ADA3-D0ABF7ACF745Q38818107-A5601492-D111-4F0B-815C-3CF9D0D25EBBQ38825756-5718BDCC-C221-4BFD-AF8A-7C4E564E7FC8Q39311633-CC92A0F8-2120-4F2D-A97B-6A69F801B375Q39742304-5DC738B6-D1EE-4D78-B1B1-680F01F59658Q42683556-73A250A8-C87A-41F7-99F9-DAA13E0DE900Q48097821-A244DC8B-BF58-4D4E-8B32-CDE8F5572D81Q52641327-DF786732-6E81-44EB-A5E6-2BEDE450A6D3
P2860
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
A network meta-analysis of eve ...... tive metastatic breast cancer.
@en
A network meta-analysis of eve ...... tive metastatic breast cancer.
@nl
type
label
A network meta-analysis of eve ...... tive metastatic breast cancer.
@en
A network meta-analysis of eve ...... tive metastatic breast cancer.
@nl
prefLabel
A network meta-analysis of eve ...... tive metastatic breast cancer.
@en
A network meta-analysis of eve ...... tive metastatic breast cancer.
@nl
P2093
P2860
P50
P1476
A network meta-analysis of eve ...... tive metastatic breast cancer.
@en
P2093
Alberto Bottini
Daniele Generali
Guy Jerusalem
Lajos Pusztai
Rosanna Tarricone
Sergio Venturini
P2860
P2888
P304
P356
10.1007/S10549-015-3453-9
P407
P577
2015-06-05T00:00:00Z